Commonwealth Equity Services
PRAX icon

Commonwealth Equity Services’s Praxis Precision Medicines PRAX Stock Holding History

Commonwealth Equity Services’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-660
Closed -$213K – 4533
2026
Q1 		$213K Sell
660
-85
-11% -$26.3K ﹤0.01% 3952
2025
Q4 		$220K Buy
+745
New +$139K ﹤0.01% 3904

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Commonwealth Equity Services's PRAX Position: Q2 2026 in Review

Commonwealth Equity Services sold out of Praxis Precision Medicines (PRAX) in Q2 2026, closing a stake of 660 shares — an estimated $213K sold.

Commonwealth Equity Services first reported a position in PRAX in Q4 2025 and held it in 2 quarters. The position peaked at $220K in Q4 2025. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Commonwealth Equity Services reported no remaining Praxis Precision Medicines position as of Q2 2026 after selling out during the quarter.
  • Commonwealth Equity Services sold 660 Praxis Precision Medicines shares in Q2 2026, an estimated $213K.
  • Commonwealth Equity Services first reported a position in Praxis Precision Medicines in Q4 2025 and held it in 2 quarters.
  • Commonwealth Equity Services's Praxis Precision Medicines position peaked at $220K in Q4 2025.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.